Incyte Total Assets 2006-2020 | INCY

Incyte total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Incyte total assets for the quarter ending June 30, 2020 were $3.212B, a 8.98% increase year-over-year.
  • Incyte total assets for 2019 were $3.427B, a 29.52% increase from 2018.
  • Incyte total assets for 2018 were $2.646B, a 14.9% increase from 2017.
  • Incyte total assets for 2017 were $2.303B, a 40.52% increase from 2016.
Incyte Annual Total Assets
(Millions of US $)
2019 $3,427
2018 $2,646
2017 $2,303
2016 $1,639
2015 $1,007
2014 $796
2013 $630
2012 $330
2011 $329
2010 $490
2009 $712
2008 $232
2007 $276
2006 $354
2005 $374
Incyte Quarterly Total Assets
(Millions of US $)
2020-06-30 $3,212
2020-03-31 $2,752
2019-12-31 $3,427
2019-09-30 $3,215
2019-06-30 $2,948
2019-03-31 $2,754
2018-12-31 $2,646
2018-09-30 $2,520
2018-06-30 $2,397
2018-03-31 $2,306
2017-12-31 $2,303
2017-09-30 $2,374
2017-06-30 $1,639
2017-03-31 $1,607
2016-12-31 $1,639
2016-09-30 $1,544
2016-06-30 $1,418
2016-03-31 $1,104
2015-12-31 $1,007
2015-09-30 $932
2015-06-30 $930
2015-03-31 $863
2014-12-31 $796
2014-09-30 $785
2014-06-30 $679
2014-03-31 $667
2013-12-31 $630
2013-09-30 $357
2013-06-30 $334
2013-03-31 $330
2012-12-31 $330
2012-09-30 $297
2012-06-30 $312
2012-03-31 $294
2011-12-31 $329
2011-09-30 $371
2011-06-30 $417
2011-03-31 $460
2010-12-31 $490
2010-09-30 $465
2010-06-30 $494
2010-03-31 $503
2009-12-31 $712
2009-09-30 $473
2009-06-30 $159
2009-03-31 $190
2008-12-31 $232
2008-09-30 $265
2008-06-30 $205
2008-03-31 $237
2007-12-31 $276
2007-09-30 $283
2007-06-30 $309
2007-03-31 $325
2006-12-31 $354
2006-09-30 $465
2006-06-30 $375
2006-03-31 $399
2005-12-31 $374
2005-09-30 $398
2005-06-30 $437
2005-03-31 $487
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $19.821B $2.159B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.567B 10.67
Amgen (AMGN) United States $138.060B 14.99
CSL (CSLLY) Australia $97.403B 0.00
Gilead Sciences (GILD) United States $77.731B 11.19
Regeneron Pharmaceuticals (REGN) United States $63.808B 24.40
Vertex Pharmaceuticals (VRTX) United States $56.803B 31.70
Illumina (ILMN) United States $47.641B 55.40
Biogen (BIIB) United States $44.329B 7.59
Seattle Genetics (SGEN) United States $34.961B 0.00
Moderna (MRNA) United States $29.176B 0.00
BeiGene (BGNE) Cayman Islands $28.695B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.206B 11.34
Genmab (GMAB) Denmark $24.097B 15.20
Genmab (GNMSF) Denmark $22.720B 5.23
BioNTech SE (BNTX) Germany $21.289B 0.00
Immunomedics (IMMU) United States $20.239B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.827B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.862B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.440B 38.47
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.515B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.372B 104.28
ARGENX SE-ADR (ARGX) Netherlands $12.687B 0.00
QIAGEN (QGEN) Netherlands $11.916B 30.24
MyoKardia (MYOK) United States $11.767B 0.00
Sarepta Therapeutics (SRPT) United States $11.181B 0.00
Bio-Techne Corp (TECH) United States $10.243B 70.28
Guardant Health (GH) United States $10.042B 0.00
Repligen (RGEN) United States $8.966B 142.31
Mirati Therapeutics (MRTX) United States $8.847B 0.00
Galapagos (GLPG) Belgium $8.418B 30.46
Ascendis Pharma (ASND) Denmark $8.374B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.707B 238.76
Exelixis (EXEL) United States $7.178B 26.10
Adaptive Biotechnologies (ADPT) United States $7.019B 0.00
Acceleron Pharma (XLRN) United States $6.997B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.719B 0.00
Novavax (NVAX) United States $6.559B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.832B 15.93
Blueprint Medicines (BPMC) United States $5.656B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.572B 0.00
Emergent Biosolutions (EBS) United States $5.233B 20.73
Vir Biotechnology (VIR) United States $5.011B 0.00
NeoGenomics (NEO) United States $4.770B 1439.67
Denali Therapeutics (DNLI) United States $4.679B 0.00
Arena Pharmaceuticals (ARNA) United States $4.665B 0.00
China Biologic Products (CBPO) China $4.479B 26.59
Amicus Therapeutics (FOLD) United States $4.443B 0.00
Twist Bioscience (TWST) United States $4.239B 0.00
Fate Therapeutics (FATE) United States $4.224B 0.00
Halozyme Therapeutics (HALO) United States $3.940B 0.00
Global Blood Therapeutics (GBT) United States $3.860B 0.00
Reata Pharmaceuticals (RETA) United States $3.790B 0.00
Bluebird Bio (BLUE) United States $3.715B 0.00
MorphoSys AG (MOR) Germany $3.688B 48.33
Insmed (INSM) United States $3.684B 0.00
Legend Biotech (LEGN) United States $3.632B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.321B 0.00
Eidos Therapeutics (EIDX) United States $2.938B 0.00
PHARMA MAR SA (PHMMF) Spain $2.876B 0.00
Alkermes (ALKS) Ireland $2.724B 57.10
Seres Therapeutics (MCRB) United States $2.597B 0.00
Sorrento Therapeutics (SRNE) United States $2.434B 0.00
I-Mab (IMAB) China $2.319B 0.00
Zymeworks (ZYME) Canada $2.097B 0.00
Editas Medicine (EDIT) United States $2.096B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.054B 0.00
Amarin (AMRN) Ireland $2.014B 0.00
Inovio Pharmaceuticals (INO) United States $1.985B 0.00
Viela Bio (VIE) United States $1.831B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Intra-Cellular Therapies (ITCI) United States $1.773B 0.00
Revance Therapeutics (RVNC) United States $1.689B 0.00
Beam Therapeutics (BEAM) United States $1.687B 0.00
Zealand Pharma (ZEAL) Denmark $1.597B 0.00
UniQure (QURE) Netherlands $1.589B 0.00
Sangamo Therapeutics (SGMO) United States $1.571B 0.00
Ligand Pharmaceuticals (LGND) United States $1.565B 52.89
Intellia Therapeutics (NTLA) United States $1.534B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.522B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Arcus Biosciences (RCUS) United States $1.364B 0.00
Epizyme (EPZM) United States $1.358B 0.00
Alcobra (ARCT) United States $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.297B 7.56
Mesoblast (MESO) Australia $1.279B 0.00
Northwest Biotherapeutics (NWBO) United States $1.238B 0.00
Mersana Therapeutics (MRSN) United States $1.223B 0.00
Cytokineticsorporated (CYTK) United States $1.161B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.148B 0.00
NGM Biopharmaceuticals (NGM) United States $1.136B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.124B 0.00
Retrophin (RTRX) United States $1.114B 0.00
Compugen (CGEN) Israel $1.082B 0.00
REGENXBIO (RGNX) United States $1.073B 0.00
Genetron Holdings (GTH) China $1.042B 0.00
Athenex (ATNX) United States $1.022B 0.00
NantKwest (NK) United States $0.995B 0.00
Adverum Biotechnologies (ADVM) United States $0.995B 0.00
Heska (HSKA) United States $0.992B 0.00
Castle Biosciences (CSTL) United States $0.984B 0.00
Myriad Genetics (MYGN) United States $0.967B 0.00
Arvinas (ARVN) United States $0.937B 0.00
Vericel (VCEL) United States $0.936B 0.00
Pliant Therapeutics (PLRX) United States $0.881B 0.00
Intrexon (PGEN) United States $0.863B 0.00
Morphic Holding (MORF) United States $0.843B 0.00
Cellectis S.A (CLLS) France $0.836B 0.00
Codexis (CDXS) United States $0.832B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.821B 0.00
Alector (ALEC) United States $0.816B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.804B 0.00
Agenus (AGEN) United States $0.803B 0.00
Protagonist Therapeutics (PTGX) United States $0.766B 0.00
Frequency Therapeutics (FREQ) United States $0.743B 0.00
MiMedx (MDXG) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.685B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.678B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 15.29
VBI Vaccines (VBIV) United States $0.666B 0.00
AnaptysBio (ANAB) United States $0.657B 0.00
Cara Therapeutics (CARA) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cel-Sci (CVM) United States $0.619B 0.00
Celldex Therapeutics (CLDX) United States $0.617B 0.00
Geron (GERN) United States $0.599B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.16
ZIOPHARM Oncology Inc (ZIOP) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
IVERIC Bio (ISEE) United States $0.571B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.551B 0.00
Anika Therapeutics (ANIK) United States $0.548B 23.94
Clovis Oncology (CLVS) United States $0.529B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.520B 0.00
Albireo Pharma (ALBO) United States $0.519B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Dynavax Technologies (DVAX) United States $0.486B 0.00
UROGEN PHARMA (URGN) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.470B 0.00
Cue Biopharma (CUE) United States $0.463B 0.00
MannKind (MNKD) United States $0.458B 0.00
Prothena (PRTA) Ireland $0.454B 0.00
Avid Bioservices (CDMO) United States $0.453B 0.00
Kala Pharmaceuticals (KALA) United States $0.451B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.440B 0.00
Forte Biosciences (FBRX) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Amryt Pharma (AMYT) United Kingdom $0.428B 0.00
Scholar Rock Holding (SRRK) United States $0.424B 0.00
Sutro Biopharma (STRO) United States $0.424B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Puma Biotechnology (PBYI) United States $0.390B 0.00
Trevena (TRVN) United States $0.387B 0.00
Syros Pharmaceuticals (SYRS) United States $0.384B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
BioDelivery Sciences (BDSI) United States $0.372B 26.36
IBio (IBIO) United States $0.370B 0.00
Athersys (ATHX) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 8.66
Aeglea BioTherapeutics (AGLE) United States $0.364B 0.00
Precision BioSciences (DTIL) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.357B 0.00
Kamada (KMDA) Israel $0.354B 16.92
Cardiff Oncology (CRDF) United States $0.353B 0.00
AC Immune SA (ACIU) Switzerland $0.350B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.340B 0.00
Spero Therapeutics (SPRO) United States $0.335B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
WAVE Life Sciences (WVE) Singapore $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
NextCure (NXTC) United States $0.313B 0.00
ChromaDex (CDXC) United States $0.308B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.308B 0.00
Pluristem Therapeutics (PSTI) Israel $0.273B 0.00
Affimed (AFMD) Germany $0.271B 0.00
Selecta Biosciences (SELB) United States $0.267B 0.00
PDL BioPharma (PDLI) United States $0.264B 0.00
Arbutus Biopharma (ABUS) United States $0.248B 0.00
Fortress Biotech (FBIO) United States $0.243B 0.00
XOMA (XOMA) United States $0.234B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
TELA Bio (TELA) United States $0.231B 0.00
Verastem (VSTM) United States $0.222B 0.00
Five Prime Therapeutics (FPRX) United States $0.218B 0.00
HOOKIPA Pharma (HOOK) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.195B 0.00
Dyadic (DYAI) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
DBV Technologies S.A (DBVT) France $0.183B 0.00
CorMedix Inc (CRMD) United States $0.181B 0.00
Cerecor (CERC) United States $0.181B 0.00
Aptinyx (APTX) United States $0.175B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
Prometic Life Sciences (LMNL) Canada $0.174B 0.00
Exicure (XCUR) United States $0.173B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
VolitionRX (VNRX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Biofrontera AG (BFRA) Germany $0.168B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Eton Pharmaceuticals (ETON) United States $0.162B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.158B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.157B 7.35
Checkpoint Therapeutics (CKPT) United States $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Bellus Health (BLU) Canada $0.144B 0.00
AquaBounty Technologies (AQB) United States $0.142B 0.00
Catalyst Biosciences (CBIO) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Cidara Therapeutics (CDTX) United States $0.132B 0.00
Aytu Bioscience (AYTU) United States $0.130B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
VTv Therapeutics (VTVT) United States $0.122B 0.00
Strongbridge Biopharma (SBBP) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.55
Unum Therapeutics (COGT) United States $0.109B 0.00
Liquidia Technologies (LQDA) United States $0.108B 0.00
Enzo Biochem (ENZ) United States $0.103B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
AIT Therapeutics (XAIR) United States $0.101B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.101B 0.00
Palatin Technologies (PTN) United States $0.100B 0.00
Cyclerion Therapeutics (CYCN) United States $0.100B 0.00
Evogene (EVGN) Israel $0.098B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
DiaMedica Therapeutics (DMAC) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Bionano Genomics (BNGO) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 71.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Curis (CRIS) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Appili Therapeutics (APLIF) Canada $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.060B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Soligenix (SNGX) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
IMMURON (IMRN) Australia $0.043B 0.00
Novogen (KZIA) Australia $0.042B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Pulmatrix (PULM) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Apricus Biosciences (SEEL) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Cleveland BioLabs (CBLI) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00